The principles of pharmacological treatment of juvenile idiopathic arthritis

Paediatrics and Child Health

Volumn 21, Issue 12, 2011, Pages 563-568

  Kelly, A ^a,b   Ramanan, A V ^a,b  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Biologics; Corticosteroids; JIA; Juvenile idiopathic arthritis; Methotrexate; NSAIDs; Sulfasalazine

Indexed keywords

ABATACEPT; ADALIMUMAB; CANAKINUMAB; CYCLOSPORIN A; DICLOFENAC; ETANERCEPT; IBUPROFEN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; PIROXICAM; PLACEBO; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; TOCILIZUMAB; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE;

ADRENAL DISEASE; ASTHMA; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; DISEASE ACTIVITY; DIZZINESS; FATIGUE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERTROPHY; GROWTH DISORDER; HEADACHE; HUMAN; HYPERTENSION; HYPERTRICHOSIS; JUVENILE RHEUMATOID ARTHRITIS; LIVER DYSFUNCTION; MUCOSA INFLAMMATION; MUSCLE CRAMP; NAUSEA AND VOMITING; OSTEOPOROSIS; PAIN; PROTEINURIA; PSEUDOPORPHYRIA; RASH; REVIEW; SWELLING;

EID: 82455209433     PISSN: 17517222     EISSN: 1878206X     Source Type: Journal    
DOI: 10.1016/j.paed.2011.07.010     Document Type: Review

References (10)

1. Beresford M.W., Baildam E.M. New advances in the management of juvenile idiopathic arthritis - 1: non-biological therapy. Arch Dis Child Edu Pract Ed 2009, 94:144-150.
2. Beresford M.W., Baildam E.M. New advances in the management of juvenile idiopathic arthritis - 2: the era of biologicals. Arch Dis Child Edu Pract Ed 2009, 94:151-156.
3. Beukelman T., Patkar N.M., Saag K.G., et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 2011, 63:465-482.
4. Hayward K., Wallace C.A. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. Arthritis Res Ther 2009, 11:216.
5. Lovell D.J., Giannini E.H., Reiff A., et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Eng J Med 2000, 342:763-769.
6. Malleson P.N. Pharmacological treatment of early or established arthritis. Arthritis in children and adolescents. Juvenile idiopathic arthritis 2006, Oxford University Press. I.S. Szer, Y. Kimura, P.N. Malleson (Eds.).
7. Ramanan A.V., Whitworth P., Baildam E.M. Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child 2003, 88:197-200.
8. Ravelli A., Viola S., Ramenghi B., Aramini L., Ruperto N., Martini A. Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. J Rheumatol 1995, 22:1574-1576.
9. Symmons D.P., Jones M., Osborne J., Sills J., Southwood T.R., Woo P. Pediatric rheumatology in the United Kingdom: data from the British Paediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996, 23:1975-1980.
10. Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis March 2002, National Institute for Clinical Excellence, ISBN: 1-84257-156-5.